Pages that link to "Q83982430"

The following pages link to Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents (Q83982430):

Displaying 18 items.

• Development of Novel Erythromycin Derivatives with Inhibitory Activity against Proliferation of Tumor Cells (Q28552828) (← links)
• Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics (Q36072425) (← links)
• Long-term treatment of clarithromycin at a low concentration improves hydrogen peroxide-induced oxidant/antioxidant imbalance in human small airway epithelial cells by increasing Nrf2 mRNA expression (Q36290459) (← links)
• Clinical application of development of nonantibiotic macrolides that correct inflammation-driven immune dysfunction in inflammatory skin diseases (Q36425959) (← links)
• Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines. (Q36525403) (← links)
• Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases. (Q37959271) (← links)
• Severe asthma: Advances in current management and future therapy (Q37971131) (← links)
• Antibiotics as immunomodulant agents in COPD (Q37982879) (← links)
• New anti-inflammatory targets for chronic obstructive pulmonary disease. (Q38131512) (← links)
• Non-antibiotic 12-membered macrolides: design, synthesis and biological evaluation in a cigarette-smoking model (Q38831487) (← links)
• Leucomycin A3, a 16-membered macrolide antibiotic, inhibits influenza A virus infection and disease progression. (Q39027294) (← links)
• Novel 12-membered non-antibiotic macrolides, EM900 series with anti-inflammatory and/or immunomodulatory activity; synthesis, structure-activity relationships and in vivo study (Q39320412) (← links)
• Effects of a Novel Nonantibiotic Macrolide, EM900, on Cytokine and Mucin Gene Expression in a Human Airway Epithelial Cell Line (Q39437504) (← links)
• The non-antibiotic macrolide EM900 inhibits rhinovirus infection and cytokine production in human airway epithelial cells. (Q40954759) (← links)
• Anti-inflammatory effects of a novel non-antibiotic macrolide, EM900, on mucus secretion of airway epithelium (Q51650200) (← links)
• 12th International Conference on the Chemistry of Antibiotics and other Bioactive Compounds (ICCA-12) (Q53139856) (← links)
• Novel desosamine-modified 14- and 15-membered macrolides without antibacterial activity (Q83889083) (← links)
• The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model (Q91833413) (← links)